Your browser doesn't support javascript.
loading
Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.
Balogh, Eszter; Chandler, Jennifer C; Varga, Máté; Tahoun, Mona; Menyhárd, Dóra K; Schay, Gusztáv; Goncalves, Tomas; Hamar, Renáta; Légrádi, Regina; Szekeres, Ákos; Gribouval, Olivier; Kleta, Robert; Stanescu, Horia; Bockenhauer, Detlef; Kerti, Andrea; Williams, Hywel; Kinsler, Veronica; Di, Wei-Li; Curtis, David; Kolatsi-Joannou, Maria; Hammid, Hafsa; Szocs, Anna; Perczel, Kristóf; Maka, Erika; Toldi, Gergely; Sava, Florentina; Arrondel, Christelle; Kardos, Magdolna; Fintha, Attila; Hossain, Ahmed; D'Arco, Felipe; Kaliakatsos, Mario; Koeglmeier, Jutta; Mifsud, William; Moosajee, Mariya; Faro, Ana; Jávorszky, Eszter; Rudas, Gábor; Saied, Marwa H; Marzouk, Salah; Kelen, Kata; Götze, Judit; Reusz, George; Tulassay, Tivadar; Dragon, François; Mollet, Géraldine; Motameny, Susanne; Thiele, Holger; Dorval, Guillaume; Nürnberg, Peter.
Afiliación
  • Balogh E; MTA-SE Lendület Nephrogenetic Laboratory, Semmelweis University, HU 1083 Budapest, Hungary.
  • Chandler JC; First Department of Pediatrics, Semmelweis University, HU 1083 Budapest, Hungary.
  • Varga M; Developmental Biology and Cancer Programme, University College London Great Ormond Street Institute of Child Health, WC1N 1EH London, United Kingdom.
  • Tahoun M; MTA-SE Lendület Nephrogenetic Laboratory, Semmelweis University, HU 1083 Budapest, Hungary; mvarga@ttk.elte.hu aoife.waters@gosh.nhs.uk tory.kalman@med.semmelweis-univ.hu.
  • Menyhárd DK; Department of Genetics, Eötvös Loránd University, HU 1117 Budapest, Hungary.
  • Schay G; Developmental Biology and Cancer Programme, University College London Great Ormond Street Institute of Child Health, WC1N 1EH London, United Kingdom.
  • Goncalves T; Clinical and Chemical Pathology Department, Faculty of Medicine Alexandria University, EG 21500, Egypt.
  • Hamar R; MTA-ELTE Protein Modeling Research Group, Eötvös Loránd University, HU 1117 Budapest, Hungary.
  • Légrádi R; Laboratory of Structural Chemistry and Biology, Eötvös Loránd University, HU 1117 Budapest, Hungary.
  • Szekeres Á; MTA-SE Lendület Nephrogenetic Laboratory, Semmelweis University, HU 1083 Budapest, Hungary.
  • Gribouval O; Department of Biophysics and Radiation Biology, Semmelweis University, HU 1085 Budapest, Hungary.
  • Kleta R; Chromosome Maintenance Research Group, University College London Cancer Institute, WC1E 6DD London, United Kingdom.
  • Stanescu H; Department of Genetics, Eötvös Loránd University, HU 1117 Budapest, Hungary.
  • Bockenhauer D; MTA-SE Lendület Nephrogenetic Laboratory, Semmelweis University, HU 1083 Budapest, Hungary.
  • Kerti A; First Department of Pediatrics, Semmelweis University, HU 1083 Budapest, Hungary.
  • Williams H; First Department of Pediatrics, Semmelweis University, HU 1083 Budapest, Hungary.
  • Kinsler V; Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM, UMR 1163, Université de Paris, FR 75015 Paris, France.
  • Di WL; Division of Medicine, Royal Free Hospital, NW3 2QG London, United Kingdom.
  • Curtis D; Nephrology, Faculty of Medical Sciences, University College London, WC1E 6DE London, United Kingdom.
  • Kolatsi-Joannou M; Division of Medicine, Royal Free Hospital, NW3 2QG London, United Kingdom.
  • Hammid H; Nephrology, Faculty of Medical Sciences, University College London, WC1E 6DE London, United Kingdom.
  • Szocs A; Division of Medicine, Royal Free Hospital, NW3 2QG London, United Kingdom.
  • Perczel K; MTA-SE Lendület Nephrogenetic Laboratory, Semmelweis University, HU 1083 Budapest, Hungary.
  • Maka E; First Department of Pediatrics, Semmelweis University, HU 1083 Budapest, Hungary.
  • Toldi G; GOSgene, Experimental and Personalised Medicine, University College London Great Ormond Street Institute of Child Health, WC1N 1EH London, United Kingdom.
  • Sava F; Genetics and Genomic Medicine, University College London Great Ormond Street Institute of Child Health, WC1N 1EH London, United Kingdom.
  • Arrondel C; Infection, Immunity, Inflammatory, and Physiological Medicine, University College London Great Ormond Street Institute of Child Health, WC1N 1EH London, United Kingdom.
  • Kardos M; University College London Genetics Institute, University College London, C1E 6AD London, United Kingdom.
  • Fintha A; Developmental Biology and Cancer Programme, University College London Great Ormond Street Institute of Child Health, WC1N 1EH London, United Kingdom.
  • Hossain A; Developmental Biology and Cancer Programme, University College London Great Ormond Street Institute of Child Health, WC1N 1EH London, United Kingdom.
  • D'Arco F; Medical Imaging Department, Neuroradiology Department, Semmelweis University, HU 1082 Budapest, Hungary.
  • Kaliakatsos M; MTA-SE Lendület Nephrogenetic Laboratory, Semmelweis University, HU 1083 Budapest, Hungary.
  • Koeglmeier J; First Department of Pediatrics, Semmelweis University, HU 1083 Budapest, Hungary.
  • Mifsud W; Department of Ophthalmology, Semmelweis University, HU 1085 Budapest, Hungary.
  • Moosajee M; First Department of Pediatrics, Semmelweis University, HU 1083 Budapest, Hungary.
  • Faro A; MTA-SE Lendület Nephrogenetic Laboratory, Semmelweis University, HU 1083 Budapest, Hungary.
  • Jávorszky E; Laboratory of Hereditary Kidney Diseases, Imagine Institute, INSERM, UMR 1163, Université de Paris, FR 75015 Paris, France.
  • Rudas G; Second Department of Pathology, Semmelweis University, HU 1091 Budapest, Hungary.
  • Saied MH; Second Department of Pathology, Semmelweis University, HU 1091 Budapest, Hungary.
  • Marzouk S; Département des Sciences Biologiques, Université du Québec à Montréal, Montréal, QC H2X 1Y4, Canada.
  • Kelen K; Department of Neuro-Radiology, Great Ormond Street Hospital, WC1N 3JH London, United Kingdom.
  • Götze J; Department of Neurology, Great Ormond Street Hospital, WC1N 3JH London, United Kingdom.
  • Reusz G; Department of Gastroenterology, Great Ormond Street Hospital, WC1N 3JH London, United Kingdom.
  • Tulassay T; Department of Histopathology, Great Ormond Street Hospital, WC1N 3JH London, United Kingdom.
  • Dragon F; Institute of Ophthalmology, University College London, EC1V 9EL London, United Kingdom.
  • Mollet G; Division of Biosciences, Department of Cell and Developmental Biology, University College London, WC1E 6BT London, United Kingdom.
  • Motameny S; MTA-SE Lendület Nephrogenetic Laboratory, Semmelweis University, HU 1083 Budapest, Hungary.
  • Thiele H; First Department of Pediatrics, Semmelweis University, HU 1083 Budapest, Hungary.
  • Dorval G; Medical Imaging Department, Neuroradiology Department, Semmelweis University, HU 1082 Budapest, Hungary.
  • Nürnberg P; Clinical and Chemical Pathology Department, Faculty of Medicine Alexandria University, EG 21500, Egypt.
Proc Natl Acad Sci U S A ; 117(26): 15137-15147, 2020 06 30.
Article en En | MEDLINE | ID: mdl-32554502
ABSTRACT
RNA modifications play a fundamental role in cellular function. Pseudouridylation, the most abundant RNA modification, is catalyzed by the H/ACA small ribonucleoprotein (snoRNP) complex that shares four core proteins, dyskerin (DKC1), NOP10, NHP2, and GAR1. Mutations in DKC1, NOP10, or NHP2 cause dyskeratosis congenita (DC), a disorder characterized by telomere attrition. Here, we report a phenotype comprising nephrotic syndrome, cataracts, sensorineural deafness, enterocolitis, and early lethality in two pedigrees males with DKC1 p.Glu206Lys and two children with homozygous NOP10 p.Thr16Met. Females with heterozygous DKC1 p.Glu206Lys developed cataracts and sensorineural deafness, but nephrotic syndrome in only one case of skewed X-inactivation. We found telomere attrition in both pedigrees, but no mucocutaneous abnormalities suggestive of DC. Both mutations fall at the dyskerin-NOP10 binding interface in a region distinct from those implicated in DC, impair the dyskerin-NOP10 interaction, and disrupt the catalytic pseudouridylation site. Accordingly, we found reduced pseudouridine levels in the ribosomal RNA (rRNA) of the patients. Zebrafish dkc1 mutants recapitulate the human phenotype and show reduced 18S pseudouridylation, ribosomal dysregulation, and a cell-cycle defect in the absence of telomere attrition. We therefore propose that this human disorder is the consequence of defective snoRNP pseudouridylation and ribosomal dysfunction.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Catarata / Proteínas Nucleares / Proteínas de Ciclo Celular / Ribonucleoproteínas Nucleolares Pequeñas / Enterocolitis / Pérdida Auditiva Sensorineural / Síndrome Nefrótico Tipo de estudio: Etiology_studies Límite: Animals / Child / Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article País de afiliación: Hungria

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Catarata / Proteínas Nucleares / Proteínas de Ciclo Celular / Ribonucleoproteínas Nucleolares Pequeñas / Enterocolitis / Pérdida Auditiva Sensorineural / Síndrome Nefrótico Tipo de estudio: Etiology_studies Límite: Animals / Child / Female / Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article País de afiliación: Hungria